Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3642944013 | Product containing durvalumab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3642945014 | Product containing durvalumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3669457015 | Durvalumab product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3714580014 | Durvalumab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Durvalumab-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Durvalumab-containing product | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
| Durvalumab-containing product | Is a | Monoclonal antibody antineoplastic agent | true | Inferred relationship | Some | ||
| Durvalumab-containing product | Has active ingredient | Durvalumab | true | Inferred relationship | Some | 1 | |
| Durvalumab-containing product | Is a | Monoclonal antibody-containing product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Durvalumab only product | Is a | True | Durvalumab-containing product | Inferred relationship | Some | |
| Durvalumab-containing product in parenteral dose form | Is a | True | Durvalumab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR